English | Español
Patient Daily | Feb 10, 2026

Sanofi reports mixed phase III results for rare disease drug venglustat
Patient Daily | Feb 10, 2026

Eli Lilly invests $3.5 billion in Pennsylvania obesity drug manufacturing plant
Patient Daily | Feb 10, 2026

GSK ends partnership on WVE-006 for AATD; future collaborations with Wave continue
Patient Daily | Feb 10, 2026

FDA prepares decisions on key therapies from REGENXBIO, Merck, Sanofi/Regeneron
Patient Daily | Feb 10, 2026

Penn Medicine expands holistic cancer care with Whole Person Care Collaborative
Patient Daily | Feb 10, 2026

Penn Medicine study finds rising use of methadone but calls for wider access
Patient Daily | Feb 10, 2026

Regulating immune response could help protect neurons in Parkinson’s disease
Patient Daily | Feb 10, 2026

Study finds people feel more empathy for loved ones’ internal bodily pain

Trending
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Danish medtech firm OSAA Innovation brings connected IV solutions to WHX Dubai 2026
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Amgen declines FDA request to withdraw rare disease drug Tavneos
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Companies advance new Duchenne muscular dystrophy treatments amid scrutiny over existing gene therapies